Place of overactive bladder in male lower urinary tract symptoms

World Journal of Urology

Volumn 27, Issue 6, 2009, Pages 723-728

  Yamaguchi, Osamu ^a   Aikawa, Ken ^a   Shishido, Keiichi ^a   Nomiya, Masanori ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Incontinence; Lower urinary tract symptoms; Overactive bladder syndrome; Urgency

Indexed keywords

ARTICLE; HUMAN; INCIDENCE; MALE; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PREVALENCE; URGE INCONTINENCE;

HUMANS; INCIDENCE; MALE; PREVALENCE; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE;

EID: 71249087969     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0470-5     Document Type: Article

References (66)

1. P Abrams L Cardozo M Fall, et al. 2002 The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society Neurourol Urodyn 21 167 178 10.1002/nau.10052 (Pubitemid 34195211)
2. DE Irwin I Milsom S Hunskaar, et al. 2006 Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study Eur Urol 50 1306 1314 10.1016/j.eururo.2006.09.019 (discussion 1314-1315) (Pubitemid 44692945)
3. CR Chapple AJ Wein P Abrams, et al. 2008 Lower urinary tract symptoms revisited: a broader clinical perspective Eur Urol 54 3 543 562 10.1016/j.eururo.2008.06.047
4. CR Chapple CG Roehrborn 2006 A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder Eur Urol 49 4 651 659 10.1016/j.eururo.2006.02.018
5. Y Homma O Yamaguchi K Hayashi 2005 An epidemiological survey of overactive bladder symptoms in Japan BJU Int 96 1314 1318 10.1111/j.1464-410X. 2005.05835.x (Pubitemid 41743931)
6. Jepsen J, Bruskewitz R (2000) Clinical manifestations and treatment. In: Lepor H (ed) Prostatic diseases. WB Saunders Co., Philadelphia, pp 127-142
7. JL Donovan P Abrams TJ Peters, et al. 1996 The ICS-'BPH' study. The psychometric validity and reliability of the ICS male questionnaire Br J Urol 77 554 562
8. TJ Peters JL Donovan HE Kay, et al. 1997 The International Continence Society "Benign prostatic hyperplasia" Study: the botherosomeness of urinary symptoms J Urol 157 885 889 10.1016/S0022-5347(01)65075-4 (Pubitemid 27066273)
9. T Knutson C Edlund M Fall, et al. 2001 BPH with coexisting overactive bladder dysfunction-an everyday urological dilemma Neurourol Urodyn 20 237 247 10.1002/nau.1001 (Pubitemid 32377204)
10. JY Lee HW Kim SJ Lee, et al. 2004 Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder BJU Int 94 817 820 10.1111/j.1464-410X.2004.05039.x (Pubitemid 39472476)
11. MJ Hyman A Groutz JG Blaivas 2001 Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings J Urol 166 550 552 10.1016/S0022-5347(05)65982-4 (discussion 553)
12. PH Abrams DJ Farrar RT Turner-Warwick, et al. 1979 The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients J Urol 121 640 642
13. K Ameda T Koyanagi M Nantani, et al. 1994 The relevance of preoperative cystometrography in patients with benign prostatic hyperplasia: correlating the findings with clinical features and outcome after prostatectomy J Urol 152 443 447
14. JT Andersson 1976 Detrusor hyperreflexia in benign infravesical obstruction J Urol 115 32
15. Abrams P (1985) The pathophysiology of male bladder outflow obstruction. In: Whitfield HN, Hendry WF (eds) Genito-urinary surgery. Churchill Livingstone, Edinburgh, pp 3760-3784
16. AW Thomas A Cannon E Bartlett, et al. 2004 The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up BJU Int 93 6 745 750 10.1111/j.1464-410X.2003.04719.x (Pubitemid 38497022)
17. JA Gosling SA Gilpin JS Dixon, et al. 1986 Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction J Urol 136 501 504
18. SC Harrison GR Hunnam P Farman, et al. 1987 Bladder instability and denervation in patients with bladder outflow obstruction Br J Urol 60 519 522 10.1111/j.1464-410X.1987.tb05033.x
19. MJ Speakman AF Brading CJ Gilpin, et al. 1987 Bladder outflow obstruction-a cause of denervation supersensitivity J Urol 138 1461 1466
20. GN Sibley 1987 The physiological response of the detrusor muscle to experimental bladder outflow obstruction in the pig Br J Urol 60 332 336 10.1111/j.1464-410X.1987.tb04979.x
21. SC Harrison DR Ferguson PT Doyle 1990 Effect of bladder outflow obstruction on the innervation of the rabbit urinary bladder Br J Urol 66 372 379 10.1111/j.1464-410X.1990.tb14957.x
22. JE Greenland AF Brading 2001 The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs J Urol 165 245 248 10.1097/00005392-200101000-00072
23. N Seki OM Karim JL Mostwin 1992 The effect of experimental urethral obstruction and its reversal on changes in passive electrical properties of detrusor muscle J Urol 148 1957 1961
24. WD Steers J Ciambotti B Etzel, et al. 1991 Alterations in afferent pathways from the urinary bladder of the rat in response to partial urethral obstruction J Comp Neurol 310 401 410 10.1002/cne.903100309
25. WD Steers WC De Groat 1988 Effect of bladder outlet obstruction on micturition reflex pathways in the rat J Urol 140 864 871
26. SA Chalfin WE Bradley 1982 The etiology of detrusor hyperreflexia in patients with infravesical obstruction J Urol 127 938 942
27. O Yokoyama K Nagano K Kawaguchi, et al. 1994 The influence of prostatic urethral anesthesia in overactive detrusor in patients with benign prostatic hyperplasia J Urol 151 1554 1556
28. H Lepor G Machi 1993 Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age Urology 42 36 40 10.1016/0090-4295(93)90332-5 (discussion 40-41) (Pubitemid 23207342)
29. MB Chancellor DA Rivas 1993 American urological association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia J Urol 150 1706 1708 (discussion 1708-1709)
30. G Schatzl C Temml J Waldmuller, et al. 2001 A comparative cross-sectional study of lower urinary tract symptoms in both sexes Eur Urol 40 213 219 10.1159/000049775 (Pubitemid 32786110)
31. P Mariappan WL Chong 2006 Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction and incontinence in men from a multiethnic Asian population: results of a regional population-based survey and comparison with industrialized nations BJU Int 98 1264 1268 10.1111/j.1464-410X.2006.06525. x (Pubitemid 44721239)
32. SA Kaplan 2006 Male pelvic health: a urological call to arms J Urol 176 2351 2352 10.1016/j.juro.2006.08.125 (Pubitemid 44666010)
33. A Ponholzer C Temml C Wehrberger, et al. 2006 The association between vascular risk factors and lower urinary tract symptoms in both sexes Eur Urol 50 581 586 10.1016/j.eururo.2006.01.031 (Pubitemid 44189048)
34. KM Azadzoi T Tarcan R Kozlowski, et al. 1999 Overactivity and structural changes in the chronically ischemic bladder J Urol 162 1768 1778 10.1016/S0022-5347(05)68236-5 (Pubitemid 29474727)
35. KM Azadzoi VM Shinde T Tarcan, et al. 2003 Increased leukotriene and prostaglandin release, and overactivity in the chronically ischemic bladder J Urol 169 1885 1891 10.1097/01.ju.0000048668.97821.f4 (Pubitemid 36443539)
36. KM Azadzoi VK Heim T Tarcan, et al. 2004 Alteration of urothelial-mediated tone in the ischemic bladder: role of eicosanoids Neurourol Urodyn 23 258 264 10.1002/nau.20029 (Pubitemid 39549987)
37. OZ Shenfeld KS Meir V Yutkin, et al. 2005 Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age? Urology 65 181 184 10.1016/j.urology.2004.08.055 (Pubitemid 40169641)
38. HS Gill FC Monson AJ Wein, et al. 1988 The effects of short-term in-vivo ischemia on the contractile function of the rabbit urinary bladder J Urol 139 1350 1354
39. H Masuda K Kihara K Saito, et al. 2008 Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats BJU Int 101 775 780 10.1111/j.1464-410X.2007.07310.x (Pubitemid 351269997)
40. CR Chapple CG Roehrborn 2006 A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder Eur Urol 49 651 658 10.1016/j.eururo.2006.02.018
41. A Tiwari NS Krishna K Nanda, et al. 2005 Benign prostatic hyperplasia: an insight into current investigational medical therapies Expert Opin Investig Drugs 14 1359 1372 10.1517/13543784.14.11.1359 (Pubitemid 41601452)
42. 1-Adrenoceptor subtypes and lower urinary tract symptoms 15 3 193 199
43. P Narayan A Tewari 1998 A second phase iii multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia. United States 93-01 study group J Urol 160 1701 1706 10.1016/S0022-5347(01)62386-3
44. H Lepor 1998 Phase iii multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin investigator group Urology 51 892 900 10.1016/S0090-4295(98)00126-5 (Pubitemid 28240845)
45. P Abrams CC Schulman S Vaage 1995 Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European tamsulosin study group Br J Urol 76 325 336 10.1111/j.1464-410X.1995.tb07709.x
46. K Kawabe M Yoshida Y Homma 2006 Silodosin, a new alpha1a-adrenoceptor- selective antagonist for treating benign prostatic hyperplasia: results of a phase iii randomized, placebo-controlled, double-blind study in Japanese men BJU Int 98 1019 1024 10.1111/j.1464-410X.2006.06448.x (Pubitemid 44536452)
47. JM Reynard 2004 Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents? Curr Opin Urol 14 13 16 10.1097/00042307- 200401000-00003 (Pubitemid 39186207)
48. KE Andersson 2004 Antimuscarinics for treatment of overactive bladder Lancet Neurol 3 46 53 10.1016/S1474-4422(03)00622-7 (Pubitemid 38018927)
49. P Abrams S Kaplan HJ De Koning Gans, et al. 2006 Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction J Urol 175 999 1004 10.1016/S0022-5347(05)00483-0 (discussion 1004) (Pubitemid 43200054)
50. CG Roehrborn P Abrams ES Rovner, et al. 2006 Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence BJU Int 97 1003 1006 10.1111/j.1464-410X.2006.06068.x
51. A Athanasopoulos K Gyftopoulos K Giannitsas, et al. 2003 Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study J Urol 169 2253 2256 10.1097/01.ju.0000067541.73285.eb (Pubitemid 36576764)
52. SA Kaplan CG Roehrborn ES Rovner, et al. 2006 Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial JAMA 296 2319 2328 10.1001/jama.296.19.2319 (Pubitemid 44749359)
53. Chapple C, Herschorn S, Abrams P et al (2009) Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with α blockers. Eur Urol 56:534-543
54. SA MacDiarmid KM Peters A Chen, et al. 2008 Efficacy and safety of extended-release oxybutinin in combination with tamsulosin for treatment of lower urinary tract symptoms in men; Randomized, double-blind, placebo-controlled study Mayo Clin Proc 83 9 1002 1010 10.4065/83.9.1002
55. R Rosen J Altwein P Boyle, et al. 2003 Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (msam-7) Eur Urol 44 637 649 10.1016/j.eururo.2003.08.015 (Pubitemid 37542920)
56. A Ponholzer C Temml R Obermayr, et al. 2004 Association between lower urinary tract symptoms and erectile dysfunction Urology 64 772 776 10.1016/j.urology.2004.05.025 (Pubitemid 39446060)
57. KT McVary 2005 Erectile dysfunction and lower urinary tract symptoms secondary to BPH Eur Urol 47 838 845 10.1016/j.eururo.2005.02.001 (Pubitemid 40745354)
58. AI El-Sakka 2005 Lower urinary tract symptoms in patients with erectile dysfunction: is there a vascular association? Eur Urol 48 319 325 10.1016/j.eururo.2005.04.032 (Pubitemid 40973319)
59. RC Rosen F Giuliano CC Carson 2005 Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) Eur Urol 47 824 837 10.1016/j.eururo.2004.12.013 (Pubitemid 40745353)
60. CE Hoesl EM Woll M Burkart, et al. 2005 Erectile dysfunction (ED) is prevalent, bothersome and underdiagnosed in patients consulting urologists for benign prostatic syndrome (BPS) Eur Urol 47 511 517 10.1016/j.eururo.2004.10.029 (Pubitemid 40357899)
61. MC Truss CG Stief S Uckert, et al. 2001 Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside World J Urol 19 344 350 10.1007/s003450100221
62. S Uckert A Kuthe U Jonas, et al. 2001 Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate J Urol 166 2484 2490 10.1016/S0022-5347(05)65621-2
63. JI Gillespie M Markerink-van Ittersum J De Vente 2006 Endogenous nitric oxide/cgmp signalling in the guinea pig bladder: evidence for distinct populations of sub-urothelial interstitial cells Cell Tissue Res 325 325 332 10.1007/s00441-005-0146-4 (Pubitemid 44050798)
64. KT McVary W Monnig JL Camps Jr, et al. 2007 Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial J Urol 177 1071 1077 10.1016/j.juro.2006.10.055 (Pubitemid 46216352)
65. CG Roehrborn 2006 Advances in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia: highlights from the 21st European Association of Urology congress, April 5-8, 2006, Paris, France Rev Urol 8 216 225
66. SA Kaplan RR Gonzalez AE Te 2007 Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction Eur Urol 51 1717 1723 10.1016/j.eururo.2007.01.033 (Pubitemid 46634750)